2nd Circ. Urges En Banc 'Pay-For-Delay' Rehearing
A federal appeals court has ruled that the "pay-for-delay" deal Bayer AG cut with Barr Laboratories Inc. to prevent the generic-drug maker from making its own version of the blockbuster antibiotic...To view the full article, register now.
Already a subscriber? Click here to view full article